A Case of Drug-Induced Liver Injury Secondary to Natalizumab

A 33-year-old Caucasian female with relapsing-remitting multiple sclerosis presented with abdominal pain, nausea, and vomiting and was found to have acute liver injury. After thorough investigation, she was diagnosed with drug-induced liver injury (DILI) thought secondary to redosing of Natalizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoiemma, Phillip P., Maddur, Haripriya, Moore, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315275/
https://www.ncbi.nlm.nih.gov/pubmed/32607262
http://dx.doi.org/10.1155/2020/7976585
_version_ 1783550223116664832
author Santoiemma, Phillip P.
Maddur, Haripriya
Moore, Christopher M.
author_facet Santoiemma, Phillip P.
Maddur, Haripriya
Moore, Christopher M.
author_sort Santoiemma, Phillip P.
collection PubMed
description A 33-year-old Caucasian female with relapsing-remitting multiple sclerosis presented with abdominal pain, nausea, and vomiting and was found to have acute liver injury. After thorough investigation, she was diagnosed with drug-induced liver injury (DILI) thought secondary to redosing of Natalizumab therapy.
format Online
Article
Text
id pubmed-7315275
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-73152752020-06-29 A Case of Drug-Induced Liver Injury Secondary to Natalizumab Santoiemma, Phillip P. Maddur, Haripriya Moore, Christopher M. Case Reports Hepatol Case Report A 33-year-old Caucasian female with relapsing-remitting multiple sclerosis presented with abdominal pain, nausea, and vomiting and was found to have acute liver injury. After thorough investigation, she was diagnosed with drug-induced liver injury (DILI) thought secondary to redosing of Natalizumab therapy. Hindawi 2020-06-16 /pmc/articles/PMC7315275/ /pubmed/32607262 http://dx.doi.org/10.1155/2020/7976585 Text en Copyright © 2020 Phillip P. Santoiemma et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Santoiemma, Phillip P.
Maddur, Haripriya
Moore, Christopher M.
A Case of Drug-Induced Liver Injury Secondary to Natalizumab
title A Case of Drug-Induced Liver Injury Secondary to Natalizumab
title_full A Case of Drug-Induced Liver Injury Secondary to Natalizumab
title_fullStr A Case of Drug-Induced Liver Injury Secondary to Natalizumab
title_full_unstemmed A Case of Drug-Induced Liver Injury Secondary to Natalizumab
title_short A Case of Drug-Induced Liver Injury Secondary to Natalizumab
title_sort case of drug-induced liver injury secondary to natalizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315275/
https://www.ncbi.nlm.nih.gov/pubmed/32607262
http://dx.doi.org/10.1155/2020/7976585
work_keys_str_mv AT santoiemmaphillipp acaseofdruginducedliverinjurysecondarytonatalizumab
AT maddurharipriya acaseofdruginducedliverinjurysecondarytonatalizumab
AT moorechristopherm acaseofdruginducedliverinjurysecondarytonatalizumab
AT santoiemmaphillipp caseofdruginducedliverinjurysecondarytonatalizumab
AT maddurharipriya caseofdruginducedliverinjurysecondarytonatalizumab
AT moorechristopherm caseofdruginducedliverinjurysecondarytonatalizumab

Ejemplares similares